#Canada #Toronto #Clinical Trials #Digital Biomarkers #Xtalks

From Signals to Strategy: Understanding Digital Biomarkers

In the rapidly evolving world of healthcare, digital biomarkers are becoming a pivotal aspect of clinical decision-making. On November 4, 2025, Xtalks will offer a free webinar titled, "From Signals to Strategy: The Next Chapter of Digital Biomarkers." This event promises to be a valuable opportunity for healthcare professionals, researchers, and industry leaders interested in harnessing the power of digital biomarkers to drive clinical and business impact.

Why Attend?
Participants will gain insights into how digital biomarkers evolve from preliminary stages into robust tools that significantly influence development decisions in therapeutics. The webinar aims to share strategies for creating scalable programs that are not only scientifically sound but also strategically aligned to meet clinical objectives. With the guidance of esteemed speakers from academia and biopharma, attendees will explore the transformative potential of digital biomarkers in managing diseases such as Parkinson's, Alzheimer's, and HIV-associated cognitive impairments.

Learn from Experts
The lineup of speakers includes notable figures such as Dr. Josh Cosman, Scientific Director of Precision Medicine at AbbVie; Dr. Leah Rubin from Johns Hopkins University; and several other industry thought leaders. These experts will share their perspectives on the operational challenges and successes they've encountered in leveraging machine learning and AI for patient monitoring.

Key Learnings
The webinar will cover critical topics essential for the successful incorporation of digital biomarkers in clinical settings. Discussions will include:

• - Validation and Governance: Understanding how to build effective governance frameworks that not only ensure data integrity but also enhance the reliability of digital biomarkers.
• - AI in Healthcare: The role of transparent AI in linking model behavior to clinical insights, making it easier for healthcare professionals to interpret data contextually.
• - Common Pitfalls: Identification of prevalent failure modes such as cohort bias and mis-specified data labels, along with practical strategies to mitigate these risks.
• - Real-world Applications: Tactical insights into aligning digital endpoints with trial designs to facilitate quicker, more effective clinical decision-making.

Register Now
Attendees will walk away with an understanding of how digital biomarkers can be transformed into decision-grade evidence, thereby fostering innovation in clinical research and aiding in accelerated clinical development timelines. To register for this pivotal webinar, please visit the Xtalks website and secure your spot.

Through this webinar, Xtalks aims to demystify the applications of digital biomarkers and empower participants with knowledge that can directly influence their work in the ever-evolving landscape of healthcare.

About Xtalks
Xtalks, powered by Honeycomb Worldwide Inc., stands at the forefront of providing educational webinars and digital content tailored for the life sciences, food, and healthcare sectors. With a commitment to keeping industry practitioners connected with the latest developments and research, Xtalks delivers a vast array of educational resources aimed at fostering professional growth and knowledge advancement.

To learn more about Xtalks or to inquire about hosting a webinar, please visit their website. Join this informative session that promises to unveil the future of digital biomarkers in today's clinical practices.